{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:49:42Z","timestamp":1762505382314},"reference-count":52,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T00:00:00Z","timestamp":1218672000000},"content-version":"vor","delay-in-days":13,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Science"],"published-print":{"date-parts":[[2008,8]]},"abstract":"<jats:p>Tumor necrosis factor\u2010related apoptosis\u2010inducing ligand (TRAIL) is a promising candidate for the treatment of cancer because it elicits cell death in many tumor cells while sparing most normal cells. Liver cancer, however, is largely resistant to TRAIL and, thus, requires sensitization for TRAIL\u2010mediated cytotoxicity. Sensitization may be achieved by cotreatment with chemotherapeutic agents. In this study, we comparatively investigated the treatment efficacy of TRAIL in combination with histone deacetylase inhibitors (HDI) <jats:italic>versus<\/jats:italic> TRAIL in combination with conventional cytostatics in the hepatocellular carcinoma cell line HepG2 and in the childhood hepatoblastoma cell line Huh6. We found that TRAIL resistance could be overcome by cotreatment with the HDI vorinostat, sodium butyrate and MS\u2010275, but not by cotreatment with the cytostatics carboplatin and etoposide. However, TRAIL combination treatment bears the risk of sensitizing otherwise TRAIL\u2010resistant normal cells. We thus explored a potential cytotoxic effect of combined HDI\/TRAIL treatment in normal hepatocytes: TRAIL in conjunction with HDI did not impose any cytotoxicity on the non\u2010malignant cells. In searching for the determinants of HDI\u2010mediated TRAIL sensitization in hepatoma cells, we observed that HDI treatment did not increase cell\u2010surface expression of proapoptotic TRAIL receptors. Instead, HDI treatment enhanced TRAIL\u2010induced cleavage of Bid. In conclusion, our data suggest that HDI are potent sensitizers to TRAIL in hepatoma cells and that the combination of HDI and TRAIL is selectively active in hepatoma cells without affecting normal hepatocytes, indicating that the combination of HDI and TRAIL may be an effective approach for the treatment of advanced liver cancer. (<jats:italic>Cancer Sci<\/jats:italic> 2008; 99: 1685\u20131692)<\/jats:p>","DOI":"10.1111\/j.1349-7006.2008.00868.x","type":"journal-article","created":{"date-parts":[[2008,8,14]],"date-time":"2008-08-14T06:14:36Z","timestamp":1218694476000},"page":"1685-1692","source":"Crossref","is-referenced-by-count":17,"title":["Differential responsiveness of human hepatoma cells <i>versus<\/i> normal hepatocytes to TRAIL in combination with either histone deacetylase inhibitors or conventional cytostatics"],"prefix":"10.1111","volume":"99","author":[{"given":"Johanna","family":"Dzieran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James F.","family":"Beck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Sonnemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2008,8,14]]},"reference":[{"key":"e_1_2_7_2_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.55.2.74"},{"key":"e_1_2_7_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14964-1"},{"key":"e_1_2_7_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(04)01508-6"},{"key":"e_1_2_7_5_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2004.tb02181.x"},{"key":"e_1_2_7_6_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0538"},{"key":"e_1_2_7_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2774"},{"key":"e_1_2_7_8_2","doi-asserted-by":"crossref","first-page":"7888","DOI":"10.1158\/0008-5472.CAN-04-4278","article-title":"Tumor necrosis factor\u2010related apoptosis\u2010inducing ligand\u2010mediated proliferation of tumor cells with receptor\u2010proximal apoptosis defects","volume":"65","author":"Baader E","year":"2005","journal-title":"Cancer Res"},{"key":"e_1_2_7_9_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-0251"},{"key":"e_1_2_7_10_2","doi-asserted-by":"publisher","DOI":"10.1053\/jhep.2000.16266"},{"key":"e_1_2_7_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/emm.2002.17"},{"key":"e_1_2_7_12_2","first-page":"1498","article-title":"TRAIL\u2010mediated apoptosis requires NF\u2010kappaB inhibition and the mitochondrial permeability transition in human hepatoma cells","volume":"36","author":"Kim YS","year":"2002","journal-title":"Hepatology"},{"key":"e_1_2_7_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1206139"},{"key":"e_1_2_7_14_2","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v9.i11.2433"},{"key":"e_1_2_7_15_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21054"},{"key":"e_1_2_7_16_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2007.04.017"},{"key":"e_1_2_7_17_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-007-0194-1"},{"key":"e_1_2_7_18_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401437"},{"key":"e_1_2_7_19_2","first-page":"227","article-title":"Histone deacetylase inhibition by valproic acid down\u2010regulates c\u2010FLIP\/CASH and sensitizes hepatoma cells towards CD95\u2010 and TRAIL receptor\u2010mediated apoptosis and chemotherapy","volume":"15","author":"Schuchmann M","year":"2006","journal-title":"Oncol Rep"},{"key":"e_1_2_7_20_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.20807"},{"key":"e_1_2_7_21_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200603000-00004"},{"key":"e_1_2_7_22_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21555"},{"key":"e_1_2_7_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jhep.2005.07.020"},{"key":"e_1_2_7_24_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.11503"},{"key":"e_1_2_7_25_2","first-page":"553","article-title":"Regulation of tumor necrosis factor\u2010related apoptosis\u2010inducing ligand sensitivity in primary and transformed human keratinocytes","volume":"60","author":"Leverkus M","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_7_26_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.23.3.777-790.2003"},{"key":"e_1_2_7_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401846"},{"key":"e_1_2_7_28_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-2635"},{"key":"e_1_2_7_29_2","doi-asserted-by":"publisher","DOI":"10.1196\/annals.1378.023"},{"key":"e_1_2_7_30_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrd2133"},{"key":"e_1_2_7_31_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00253-007-0912-1"},{"key":"e_1_2_7_32_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1210620"},{"key":"e_1_2_7_33_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.10632"},{"key":"e_1_2_7_34_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.2.674"},{"key":"e_1_2_7_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0091-679X(08)61797-5"},{"key":"e_1_2_7_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10637-005-5854-9"},{"key":"e_1_2_7_37_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrm2312"},{"key":"e_1_2_7_38_2","doi-asserted-by":"publisher","DOI":"10.1023\/A:1016119328968"},{"key":"e_1_2_7_39_2","doi-asserted-by":"publisher","DOI":"10.1136\/gut.2006.118059"},{"key":"e_1_2_7_40_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21740"},{"key":"e_1_2_7_41_2","doi-asserted-by":"publisher","DOI":"10.2174\/138920107780487456"},{"key":"e_1_2_7_42_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20266"},{"key":"e_1_2_7_43_2","doi-asserted-by":"publisher","DOI":"10.1002\/hep.21846"},{"key":"e_1_2_7_44_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0500369102"},{"key":"e_1_2_7_45_2","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-5-27"},{"key":"e_1_2_7_46_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2629"},{"key":"e_1_2_7_47_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207830"},{"key":"e_1_2_7_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2004.04.038"},{"key":"e_1_2_7_49_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1208585"},{"key":"e_1_2_7_50_2","first-page":"1273","article-title":"Simultaneous activation of the intrinsic and extrinsic pathways by histone deacetylase (HDAC) inhibitors and tumor necrosis factor\u2010related apoptosis\u2010inducing ligand (TRAIL) synergistically induces mitochondrial damage and apoptosis in human leukemia cells","volume":"2","author":"Rosato RR","year":"2003","journal-title":"Mol Cancer Ther"},{"key":"e_1_2_7_51_2","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2407-6-214"},{"key":"e_1_2_7_52_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.cdd.4401977"},{"key":"e_1_2_7_53_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-007-0227-8"}],"container-title":["Cancer Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1349-7006.2008.00868.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1349-7006.2008.00868.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T21:46:27Z","timestamp":1697233587000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1349-7006.2008.00868.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":52,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["10.1111\/j.1349-7006.2008.00868.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1349-7006.2008.00868.x","archive":["Portico"],"relation":{},"ISSN":["1347-9032","1349-7006"],"issn-type":[{"value":"1347-9032","type":"print"},{"value":"1349-7006","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}